General - Therapies
Device General - Therapies_ENDO
General payments
$4,648,794
Research payments
$528,418
Through program year 2025, $4,648,794 in general payments and $528,418 in research payments were reported against General - Therapies (General - Therapies_ENDO).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,639,230 | 1,932 |
| 2025 | Research | $411,918 | 7 |
| 2024 | Research | $116,500 | 4 |
| 2022 | General | $968,066 | 2,004 |
| 2021 | General | $41,498 | 35 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 45 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,971 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.